Literature DB >> 1875334

Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity.

S Thaisrivongs1, A G Tomasselli, J B Moon, J Hui, T J McQuade, S R Turner, J W Strohbach, W J Howe, W G Tarpley, R L Heinrikson.   

Abstract

The peptidomimetic template and the dihydroxyethylene isostere insert that were applied successfully to the design of renin inhibitors have been extended to the related protease from human immunodeficiency virus (HIV). The present report describes the structure-activity study leading to the identification of an inhibitor with a Ki of less than 1 nM for the HIV type-1 protease (compound II). This compound, containing a diol insert, is highly effective in blocking polyprotein processing in in vitro cell culture assays. Results obtained from kinetic analysis, studies of the stereochemistry of the insert, and modeling have led to insights as to the requisites involved in the active site-inhibitor interaction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875334     DOI: 10.1021/jm00112a005

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Large scale purification and refolding of HIV-1 protease from Escherichia coli inclusion bodies.

Authors:  J O Hui; A G Tomasselli; I M Reardon; J M Lull; D P Brunner; C S Tomich; R L Heinrikson
Journal:  J Protein Chem       Date:  1993-06

2.  Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling.

Authors:  N Thanki; J K Rao; S I Foundling; W J Howe; J B Moon; J O Hui; A G Tomasselli; R L Heinrikson; S Thaisrivongs; A Wlodawer
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

Review 3.  Viral proteases as targets for chemotherapeutic intervention.

Authors:  C U Hellen; E Wimmer
Journal:  Curr Opin Biotechnol       Date:  1992-12       Impact factor: 9.740

4.  In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease.

Authors:  J A Partaledis; K Yamaguchi; M Tisdale; E E Blair; C Falcione; B Maschera; R E Myers; S Pazhanisamy; O Futer; A B Cullinan
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

5.  Effects of U-75875, a peptidomimetic inhibitor of retroviral proteases, on simian immunodeficiency virus infection in rhesus monkeys.

Authors:  L N Martin; K F Soike; M Murphey-Corb; R P Bohm; E D Roberts; T J Kakuk; S Thaisrivongs; T J Vidmar; M J Ruwart; S R Davio
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 6.  Protein crystallography and infectious diseases.

Authors:  C L Verlinde; E A Merritt; F Van den Akker; H Kim; I Feil; L F Delboni; S C Mande; S Sarfaty; P H Petra; W G Hol
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.